| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca32fd2a44fd326ffd027a75a57bd13f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-814
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00 |
| filingDate |
1989-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8c6e6bb9e3ecfe068cf2b759f470cf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72ccc4522d3610fe5dd9f3f39dc2bb45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d12049c45358974a5596faf59cfb91e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0c95018ad197de01ffde12a683d618c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebb570dc0fb60be4110c54fcb55c4b3a |
| publicationDate |
1990-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H02131432-A |
| titleOfInvention |
Acquisition of protective antigen against pertussis infection and toxicity processes |
| abstract |
PURPOSE: To obtain an antigenic adenylic acid cyclase(AC) preparation not having the danger of a side effect (e.g. allergic encephalitis) related to pertussigen by using B. parapertussis or its mutant. n CONSTITUTION: This AC preparation is obtained by using B. parapertussis or its mutant (e.g. the hemolytic clone of B. parapertussis capable of inducing acute edematous hemolytic alveolitis). The AC preparation is specifically recognized with specific polyclonal and monoclonal anti-B. pertussis AC, can antigenically cross-react with the B. pertussis AC, is specifically recognized with a polyclonal anti-AC antibody having a mol.wt. of 43±4.3 to 45±4.5KD and enhanced to active AC, lacks an activity capable of activating adenylic acid cyclase calmodulin(CaM) and affinity of CaM, and contains an inactive protein having a mol.wt. of 43±4.3KD. n COPYRIGHT: (C)1990,JPO |
| priorityDate |
1988-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |